NMPA Approval

Pramipexole Dihydrochloride Sustained Release Tablets

Approval Number

国药准字H20233148

Company成都百裕制药股份有限公司

Registration Date

February 14, 2023

Drug Information

Generic Name

盐酸普拉克索缓释片

Dosage Form

片剂

Strength

0.75mg（按C₁₀H₁₇N₃S•2HCl•H₂O计）

Drug Type

化学药品

Registration Date

February 14, 2023

Company Information

Applicant Company

Company Name成都百裕制药股份有限公司

Company Address

成都市温江区成都海峡两岸科技产业开发园

Manufacturing Company

Company Name四川宏明博思药业有限公司

Company Address

成都高新区合作路343号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸普拉克索缓释片 - NMPA 批准文号 | MedPath